Profilo
Tori Arens formerly worked at Aerie Pharmaceuticals, Inc., as Vice President-Drug Product Manufacturing from 2017 to 2021.
Ms. Arens received her graduate degree from The University of North Carolina at Charlotte.
Precedenti posizioni note di Tori Arens
| Società | Posizione | Fine |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2021 |
Formazione di Tori Arens
| The University of North Carolina at Charlotte | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Borsa valori
- Insiders
- Tori Arens
